Vitamin D receptor polymorphisms and associated miRNAs in the development of breast cancer in African American women

被引:0
作者
Aloufi, Abrar [1 ,6 ]
Aubee, Joseph [1 ,7 ]
Vargas, Kevin Monsalve [2 ]
Apprey, Victor [4 ]
Thompson, Karl [1 ]
Copeland, Robert [1 ]
Kanaan, Yasmine [1 ]
Ricks-Santi, Luisel [5 ]
Brim, Hassan [3 ]
Abbas, Muneer [1 ,4 ]
机构
[1] Howard Univ, Dept Microbiol, Washington, DC 20059 USA
[2] MedStar Georgetown Univ Hosp, Pre Postoperat Serv, Washington, DC USA
[3] Howard Univ, Dept Pathol, Washington, DC 20059 USA
[4] Howard Univ, Natl Human Genome Ctr, Washington, DC USA
[5] Univ Florida, Coll Pharm, Gainesville, FL USA
[6] Al Rayan Coll, Dept Microbiol, Al Madina, Saudi Arabia
[7] Mem Sloan Kettering Canc Ctr, New York, NY USA
关键词
Breast Cancer; Vitamin D receptor; Single Nucleotide Polymorphism; miRNA; Triple Negative Breast Cancer; Arrican American; GENE POLYMORPHISMS; RISK; CELLS; MICRORNAS; PROLIFERATION; PREVALENCE; APOPTOSIS; VARIANTS; BRCA1;
D O I
10.1016/j.gene.2024.148695
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Breast cancer (BCa) is a prevalent form of cancer in women, exhibiting varying rates and distribution across different ethnic groups. Among these groups, African American (AA) women have the highest incidence of BCa and the lowest levels of Vitamin D (VD). Numerous studies have explored the connection between variations in the VDR gene and BCa risk, particularly in different populations, but research on the AA population remains limited. Epigenetic modifications, including specific microRNAs (miRNAs), can influence gene expression without altering the genetic code and have been implicated in cancer initiation and progression. Our hypothesis suggests that VDR gene variations may increase BCa risk in AA women and that changes in miRNA expression profiles could contribute to BCa development. Using data from the 1000 Genome Project, we identified five VDR gene variants with significant frequency differences between AA and European-American (EA) populations. We genotyped 404 African American BCa cases and controls for five variants using TaqMan (R) assays. SNPstats assessed their association with BCa risk. The rs1544410 variant's recessive model (A/A) showed a decreased BCa risk in AA (odds ratio 0.33, 95% CI: 0.15-0.73, p-value 0.0041). Conversely, the rs2853563 variant's recessive model (A/A) was linked to an increased BCa risk (odds ratio 4.04, 95% CI: 1.49-10.95, p-value 0.0022). We investigated miRNA expression influenced by VD in HCC1806 Triple-Negative Breast Cancer (TNBC) cell lines with the A/A allele for rs2853563. nCounter (R) Nanostring technology assessed miRNA profiles after calcitriol treatment. Our results indicated that calcitriol treatment led to reduced expression of six miRNAs, four of which are associated with tumor suppression in the presence of the AA genotype in TNBC cell lines. These findings suggest that specific VDR genotypes could have a potential effect on the miRNAs expression which could potentially serve as markers for cell proliferation in TNBC.
引用
收藏
页数:11
相关论文
共 63 条
  • [1] Redefining Human Vitamin D Sufficiency: Back to the Basics
    Adams, John S.
    Ramin, Jonathan
    Rafison, Brandon
    Windon, Charles
    Windon, Annika
    Liu, Philip T.
    [J]. BONE RESEARCH, 2013, 1 : 2 - 10
  • [2] [Anonymous], 2017, TUMOUR BIOL, DOI [10.1177/1010428317727738, DOI 10.1177/1010428317727738]
  • [3] Association between Serum 25-hydroxy Vitamin D Concentration and Taql Vitamin D Receptor Gene Polymorphism among Jordanian Females with Breast Cancer
    Atoum, Manar Fayiz
    Al-Khatib, Yasmeen Mohammad
    [J]. CHINESE MEDICAL JOURNAL, 2017, 130 (09) : 1074 - 1078
  • [4] Tamoxifen Represses miR-200 MicroRNAs and Promotes Epithelial-to-Mesenchymal Transition by Up-Regulating c-Myc in Endometrial Carcinoma Cell Lines
    Bai, Jiu-Xu
    Yan, Bo
    Zhao, Zhi-Ning
    Xiao, Xiao
    Qin, Wei-Wei
    Zhang, Rui
    Jia, Lin-Tao
    Meng, Yan-Ling
    Jin, Bo-Quan
    Fan, Dai-Ming
    Wang, Tao
    Yang, An-Gang
    [J]. ENDOCRINOLOGY, 2013, 154 (02) : 635 - 645
  • [5] Vitamin D Metabolism, Mechanism of Action, and Clinical Applications
    Bikle, Daniel D.
    [J]. CHEMISTRY & BIOLOGY, 2014, 21 (03): : 319 - 329
  • [6] Bin Alwi Z, 2005, MALAYS J MED SCI, V12, P4
  • [7] Brzezinski M., 2006, Foundations of Anesthesia, VSecond, P71
  • [8] Center for Desease Control and Prevention, 2018, Cancer Statistics At a Glance
  • [9] Vitamin D as a promising anticancer agent
    Chakraborti, Chandra Kanti
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2011, 43 (02) : 113 - 120
  • [10] Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer
    Cho, Beomyoung
    Han, Yunan
    Lian, Min
    Colditz, Graham A.
    Weber, Jason D.
    Ma, Cynthia
    Liu, Ying
    [J]. JAMA ONCOLOGY, 2021, 7 (07) : 1016 - 1023